Skip to site menu Skip to page content

Nomad Foods to close factory in Switzerland

The UK-headquartered owner of the Birds Eye, Iglo and Findus brands said the proposed move is aligned with the “long-term productivity programme” unveiled last year.

Shivam Mishra April 29 2026

Nomad Foods plans to close its Rorschach manufacturing plant in Switzerland by the end of the year as part of the European frozen-food group's savings plan.

In a statement, the UK-headquartered owner of the Birds Eye, Iglo and Findus brands said the proposed move is aligned with its “long-term productivity programme” unveiled last year.

The closure would affect 45 full-time employees, with consultations with staff running until 8 May.

As outlined in September, Nomad Foods is targeting €200m ($233.1m) in operational savings over its 2026 to 2028 financial years, with efficiencies expected across procurement, logistics and overheads.

At the time, the company said the savings would be “broad-based”, although the biggest contribution is set to come from a procurement transformation programme.

It is also looking to improve utilisation across its manufacturing network, reduce logistics costs and unlock overhead efficiencies.

Nomad Foods believes the savings will allow the business to make “targeted reinvestments” and “mitigate” pressure from inflation.

Production currently carried out at Rorschach, including frozen meals such as Plätzli, lasagne and cannelloni sold under the Findus brand in Switzerland, would be transferred to other facilities in Italy and Spain.

Eduardo Bachiega, Nomad Foods' chief supply officer, said: “This is a very difficult decision and over the coming months we will work closely with all affected employees to provide support throughout this transition.”

The company said supply to the Swiss market would not be disrupted.

The announcement comes as Nomad Foods navigates a challenging trading environment.

Two months ago, chief executive Dominic Brisby, who took over in January, described the business as being in a “transition year” marked by “some near-term turbulence”. 

In 2025, organic sales fell 1.9% to €3bn, with volumes down 1.4% and price/mix slipping 0.5%.

Reported revenue declined 2.2%. For 2026, the company expects organic sales to fall by a further 2-5%.

Adjusted EBITDA is forecast to decline 5-10%, after falling 7.5% in 2025, while adjusted EPS is expected to drop 4-13%, compared to a 6.7% decline last year.

Uncover your next opportunity with expert reports

Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close